Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status-Reference-Cited by-同舟云学术

Association Between Platelet Reactivity and Long-Term Bleeding Complications After Percutaneous Coronary Intervention According to Diabetes Status

Published:2022-05 Issue: Volume:171 Page:49-54
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Cavallari Ilaria,Patti Giuseppe,Maddaloni Ernesto^ORCID,Veneziano Francesco,Mangiacapra Fabio,Ricottini Elisabetta,Buzzetti Raffaella^ORCID,Ussia Gian Paolo,Grigioni Francesco

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference30 articles.

1. Working Group on Thrombosis of the Italian Society of Cardiology. Prevention of atherothrombotic events in patients with diabetes mellitus: from antithrombotic therapies to new-generation glucose-lowering drugs;Patti;Nat Rev Cardiol,2019

2. Reduction in ischemic events with ticagrelor in diabetic patients with prior myocardial infarction in PEGASUS-TIMI 54;Bhatt;J Am Coll Cardiol,2016

3. Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38

4. Comparison of platelet reactivity and periprocedural outcomes in patients with versus without diabetes mellitus and treated with clopidogrel and percutaneous coronary intervention;Mangiacapra;Am J Cardiol,2010

5. Insulin-requiring versus noninsulin-requiring diabetes and thromboembolic risk in patients with atrial fibrillation: PREFER in AF;Patti;J Am Coll Cardiol,2017

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Aggregation Test is Useful for Predicting Postprocedural Bleeding after Gastric Endoscopic Submucosal Dissection under Continuous Antiplatelet Agents;2024-08-17

2. Questions and answers on the use of aspirin for primary prevention of cardiovascular disease in diabetes;Diabetes Research and Clinical Practice;2022-09